AR079440A1 - Compuestos heterociclicos antivirales - Google Patents
Compuestos heterociclicos antiviralesInfo
- Publication number
- AR079440A1 AR079440A1 ARP100104600A ARP100104600A AR079440A1 AR 079440 A1 AR079440 A1 AR 079440A1 AR P100104600 A ARP100104600 A AR P100104600A AR P100104600 A ARP100104600 A AR P100104600A AR 079440 A1 AR079440 A1 AR 079440A1
- Authority
- AR
- Argentina
- Prior art keywords
- hydrogen
- alkyl
- benzofuran
- alkylsulfonyl
- dihydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Estos compuestos son inhibidores de la polimerasa NS5b del virus de la hepatitis C. Se describen también composiciones y su uso para tratar una infeccion del HCV y para inhibir la replicacion del HCV. Reivindicacion 1: Un compuesto de la formula (1) en la que: la línea de puntos indica un enlace sencillo o un doble enlace; n es un numero de cero a dos; Ra y Rb son, con independencia de cada aparicion (a) hidrogeno, (b) alquilo C1-6, (c) alquilsulfonilo C1-6, (d) acilo C1-6, (e) haloalquilsulfonilo C1-6, (f) cicloalquil-sulfonilo C3-7, (g) (cicloalquil C3-7)-alquilsulfonilo C1-3, (h) (alcoxi C1-6)-alquilsulfonilo C1-6, (i) SO2(CH2)0-6NRcRd o (k) haloalquilo C1-6; Rc y Rd son con independencia hidrogeno o alquilo C1-6, o junto con el nitrogeno al que están unidos forman una amina cíclica; R1 es hidrogeno o alquilo C1-3; R3 y R4 juntos son CH2-O y junto con los átomos a los que están unidos forman un 2,3-dihidro-benzofurano y R2 es hidrogeno o alcoxi C1-6 o R2 y R3 juntos son CH2-O y junto con los átomos a los que están unidos forman un 2,3-dihidro-benzofurano y R4 es hidrogeno; R5 son con independencia de cada aparicion alquilo C1-3; o una sal farmacéuticamente aceptable del mismo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28613609P | 2009-12-14 | 2009-12-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR079440A1 true AR079440A1 (es) | 2012-01-25 |
Family
ID=43446588
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP100104600A AR079440A1 (es) | 2009-12-14 | 2010-12-13 | Compuestos heterociclicos antivirales |
Country Status (12)
Country | Link |
---|---|
US (1) | US20110123490A1 (es) |
EP (1) | EP2513092A1 (es) |
JP (1) | JP2013513584A (es) |
KR (1) | KR20120104343A (es) |
CN (1) | CN102652134A (es) |
AR (1) | AR079440A1 (es) |
BR (1) | BR112012014299A2 (es) |
CA (1) | CA2780526A1 (es) |
MX (1) | MX2012006513A (es) |
RU (1) | RU2012129657A (es) |
TW (1) | TW201144298A (es) |
WO (1) | WO2011073114A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2379534A1 (en) * | 2008-12-22 | 2011-10-26 | F. Hoffmann-La Roche AG | Heterocyclic antiviral compounds |
DK2509961T3 (en) | 2009-12-11 | 2016-05-17 | Autifony Therapeutics Ltd | Imidazolidinedione derivatives |
EP2649066B1 (en) | 2010-12-06 | 2015-10-21 | Autifony Therapeutics Limited | Hydantoin derivatives useful as kv3 inhibitors |
JP6008953B2 (ja) | 2011-06-07 | 2016-10-19 | アウトイフオンイ トヘラペウトイクス リミテッド | Kv3阻害剤としてのヒダントイン誘導体 |
CN103974944B (zh) * | 2011-12-06 | 2016-11-02 | 奥蒂福尼疗法有限公司 | 用作kv3抑制剂的乙内酰脲衍生物 |
US9422252B2 (en) | 2012-05-22 | 2016-08-23 | Autifony Therapeutics Limited | Triazoles as Kv3 inhibitors |
CN104334548A (zh) | 2012-05-22 | 2015-02-04 | 奥蒂福尼疗法有限公司 | 作为kv3抑制剂的乙内酰脲衍生物 |
WO2015197028A1 (en) * | 2014-06-28 | 2015-12-30 | Sunshine Lake Pharma Co., Ltd. | Compounds as hepatitis c virus (hcv) inhibitors and uses thereof in medicine |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2639226T3 (en) * | 2007-09-17 | 2016-12-19 | Abbvie Bahamas Ltd | Anti-infective pyrimidines and uses thereof |
UY31344A1 (es) * | 2007-09-17 | 2009-04-30 | Metansulfonamidas n-(3-ter-butil-5-(2,4-dioxo-3,4-dihidropirimidin-1(2h)-il)-2-metoxi-aril) sustituidas, solvatos, hidratos, formas cristalinas y sus sales farmacéuticamente aceptables,proceso de preparación,composiciones y aplicaciones. | |
WO2010111437A1 (en) * | 2009-03-25 | 2010-09-30 | Abbott Laboratories | Antiviral compounds and uses thereof |
-
2010
- 2010-12-13 CN CN2010800564841A patent/CN102652134A/zh active Pending
- 2010-12-13 JP JP2012542574A patent/JP2013513584A/ja active Pending
- 2010-12-13 AR ARP100104600A patent/AR079440A1/es unknown
- 2010-12-13 BR BR112012014299A patent/BR112012014299A2/pt not_active IP Right Cessation
- 2010-12-13 KR KR1020127018270A patent/KR20120104343A/ko not_active Application Discontinuation
- 2010-12-13 CA CA2780526A patent/CA2780526A1/en not_active Abandoned
- 2010-12-13 EP EP10787145A patent/EP2513092A1/en not_active Withdrawn
- 2010-12-13 WO PCT/EP2010/069442 patent/WO2011073114A1/en active Application Filing
- 2010-12-13 MX MX2012006513A patent/MX2012006513A/es unknown
- 2010-12-13 TW TW099143545A patent/TW201144298A/zh unknown
- 2010-12-13 RU RU2012129657/04A patent/RU2012129657A/ru unknown
- 2010-12-14 US US12/967,657 patent/US20110123490A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2780526A1 (en) | 2011-06-23 |
TW201144298A (en) | 2011-12-16 |
EP2513092A1 (en) | 2012-10-24 |
MX2012006513A (es) | 2012-07-17 |
RU2012129657A (ru) | 2014-01-27 |
BR112012014299A2 (pt) | 2016-07-05 |
WO2011073114A1 (en) | 2011-06-23 |
CN102652134A (zh) | 2012-08-29 |
KR20120104343A (ko) | 2012-09-20 |
JP2013513584A (ja) | 2013-04-22 |
US20110123490A1 (en) | 2011-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR079440A1 (es) | Compuestos heterociclicos antivirales | |
AR078397A1 (es) | Compuestos heterociclicos antivirales | |
AR075510A1 (es) | Inhibidores del virus de la hepatitis c | |
AR127309A2 (es) | Derivados de piridazinona | |
AR049291A1 (es) | Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso | |
AR069490A1 (es) | Agonistas de los receptores de glucocorticoides | |
AR054035A1 (es) | Derivados benzodioxano y benzodioxolano y uso de los mismos | |
AR086094A1 (es) | Derivados nucleosidicos 2’-azido sustituidos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar enfermedades virales por vhc | |
AR079634A1 (es) | Inhibidores del virus de la hepatitis c | |
AR078152A1 (es) | Compuestos heterociclicos, utiles para el tratamiento de hcv y composiciones farmaceuticas que los comprenden | |
AR081653A1 (es) | Inhibidores del virus de la hepatitis c | |
PE20140302A1 (es) | Inhibidores del virus de la hepatitis c | |
AR061057A1 (es) | Derivados de pirazolo(3,4-d)pirimidina utiles para desordenes respiratorios | |
AR100808A1 (es) | Inhibidores de fosfatidilinositol 3-quinasa | |
AR082633A1 (es) | Analogos de tetraciclina | |
AR067757A1 (es) | Derivados de imidazo[4,5-c]piridin-2-ona, composiciones farmaceuticas que los contienen, procedimiento para su preparacion y uso de los mismos como agentes antivirales. | |
AR064389A1 (es) | Derivados heterociclicos de nicotinamida utiles en el tratamiento de afecciones y enfermedades alergicas y respiratorias, y composiciones farmaceuticas que los contienen. | |
AR057770A1 (es) | Inhibidores de la p38-map-quinasa y composicion farmaceutica | |
AR080859A1 (es) | Derivados 1,2,4 triazolo-piridinicos inhibidores no nucleosidicos de la transcriptasa inversa, utiles para tratar infecciones por vih y composiciones farmaceuticas que los contienen. | |
AR107170A1 (es) | Compuestos heterocíclicos tricíclicos condesados como inhibidores de integrasa del vih | |
UY29393A1 (es) | Nuevos derivados de amidas, sales farmacéuticas aceptables, composiciones que los contienen, procedimientos de preparación y aplicaciones. | |
RU2012146777A (ru) | Макроциклические ингибиторы интегразы | |
AR076579A1 (es) | Espironucleosidos uracilicos oxetanicos, composiciones farmaceuticas que los contienen y uso de los mismos como inhibidores del virus de la hepatitis c (vhc). | |
AR069789A1 (es) | Pirazoles condensados, una composicion farmaceutica que los contiene y su uso en la preparacion de un medicamento para el tratamiento del sida o el arc. | |
CO6180507A2 (es) | Derivado de 2-piridincarboxamida que tiene efecto activador de gk |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |